In the summer of 2016, Keller Rohrback L.L.P. filed Class Action Complaints California and Arizona federal courts against Theranos, Inc. and Walgreens Boot Alliance.
Keller Rohrback L.L.P. is investigating recent reports that OptumRx, UnitedHealthcare, and Cigna are forcing patients to overpay for prescriptions by charging a “clawback” on many commonly-used medications.
According to a recent report by STAT news, “Mylan Pharmaceuticals has [begun] . . . a surreptitious lobbying campaign to have its [EpiPen] device added to a coveted list of preventive services that is maintained by the federal government.”
Keller Rohrback L.L.P., which over a year ago filed the first consumer class action lawsuit against Wells Fargo Bank, N.A. for opening unauthorized accounts, has begun investigating similar practices at other consumer banks.